6 December, 2021 | ChargePoint Technology
The global injectables sector is growing rapidly, both due to the rise of biopharma to treat serious chronic conditions, but also as part of the ongoing COVID-19 mass vaccination programme. With aseptic processing encompassing a crucial aspect of parenteral preparation, Ben Wylie, our Senior Product Manager, spoke to Pharmaceutical Manufacturing and Packing Sourcer (PMPS) about the challenges for CDMOs concerning effective aseptic containment of parenteral production lines. To meet new guidelines for closed processing, CDMOs are increasingly employing innovative technologies such as single-use technology and “smart” factory concepts. These technologies are detailed in the full article and their role in meeting the growing parenteral demand whilst ensuring appropriate sterile containment is expanded upon.
Read the full article here